[{"Assets_0_Q3_USD":54453000.0,"CommonStockSharesOutstanding_0_Q3_shares":10978916.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-5927000.0,"NetIncomeLoss_1_Q3_USD":-2755000.0,"NetIncomeLoss_3_Q3_USD":-7181000.0,"StockholdersEquity_0_Q3_USD":52292000.0,"Ticker":"KRYS","CIK":"1711279","name":"KRYSTAL BIOTECH, INC.","OfficialName":"Krystal Biotech Inc. Common Stock","form":"10-Q","period":"20180930","fy":"2018.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1834745088.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20181105"}]